Skip to main content
GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.0818
+0.0004 (0.49%)
Apr 29, 2026, 10:08 AM CET

GenSight Biologics Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-12.04-14-26.22-27.63-28.62
Upgrade
Depreciation & Amortization
0.471.062.181.060.93
Upgrade
Stock-Based Compensation
0.390.780.59-3.364.83
Upgrade
Other Operating Activities
1.02-1.65-3.660.090.88
Upgrade
Change in Accounts Receivable
---00.76-0.7
Upgrade
Change in Accounts Payable
-0.520.16-2.23-2.152.4
Upgrade
Change in Other Net Operating Assets
1.510.724.69-2.523.14
Upgrade
Operating Cash Flow
-9.17-12.94-24.66-33.75-17.14
Upgrade
Capital Expenditures
-0-0-0.01-0.25-0.03
Upgrade
Investment in Securities
0.190.020.220.420.02
Upgrade
Other Investing Activities
-0-0---
Upgrade
Investing Cash Flow
0.180.020.210.17-0.02
Upgrade
Long-Term Debt Issued
--14.1810.8-
Upgrade
Long-Term Debt Repaid
-1.25-2.9-1.87-8.68-3.65
Upgrade
Net Debt Issued (Repaid)
-1.25-2.912.312.12-3.65
Upgrade
Issuance of Common Stock
6.1815.813.96030
Upgrade
Repurchase of Common Stock
--0.03-0.1-0.19-0.31
Upgrade
Other Financing Activities
4.020.65-0.31-1.83-2.3
Upgrade
Financing Cash Flow
8.9413.5415.860.123.74
Upgrade
Foreign Exchange Rate Adjustments
0.01-0.290.12-0.19-0.24
Upgrade
Miscellaneous Cash Flow Adjustments
-0---0
Upgrade
Net Cash Flow
-0.050.33-8.48-33.686.35
Upgrade
Free Cash Flow
-9.17-12.94-24.67-34.01-17.17
Upgrade
Free Cash Flow Margin
-1407.06%-492.88%-832.42%-698.97%-222.74%
Upgrade
Free Cash Flow Per Share
-0.06-0.14-0.51-0.73-0.38
Upgrade
Cash Interest Paid
0.210.280.371.870.84
Upgrade
Levered Free Cash Flow
-7.24-6.69-14.13-29.49-13.79
Upgrade
Unlevered Free Cash Flow
-5.44-5.72-12.16-27.83-12.43
Upgrade
Change in Working Capital
0.990.872.45-3.924.84
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.